With the threat of Trump administration's tariffs swirling and biopharma companies bracing for impact, many are announcing ...

Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at ...

The science-services and instruments provider is expanding operations in the U.S. as companies rearrange manufacturing to avoid new global tariffs. The pharmaceutical industry has long been exempt ...

Q1 2025 Earnings Call Transcript April 23, 2025 Thermo Fisher Scientific Inc. beats earnings expectations. Reported EPS is $5 ...

Thermo Fisher kicked off 2025 with strong Q1 results, banking $10.36 billion in revenue and flexing its R&D muscles. CEO Marc ...

Marc Casper; Chairman of the Board, President, Chief Executive Officer; Thermo Fisher Scientific Inc Stephen Williamson; Chief Financial Officer, Senior Vice President; Thermo Fisher Scientific Inc I ...

Company management said they expect the tariff battle with China to cause weakening of $375 million in adjusted operating income.

Life sciences company Thermo Fisher (NYSE:TMO) reported in Q1 CY2025, but sales were flat year on year at $10.36 billion. Its ...

Thermo Fisher cut its 2025 EPS and revenue outlook due to tariffs and U.S. policy changes, expecting a $400 million sales hit ...

Thermo Fisher CEO Marc Casper noted strong performance in Q1 2025, delivering $10.36 billion in revenue. Adjusted EPS grew 1% to $5.15. Adjusted operating income was $2.27 billion, with an adjusted ...